319 related articles for article (PubMed ID: 12629668)
1. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes.
Anlauf M; Schäfer MK; Eiden L; Weihe E
J Comp Neurol; 2003 Apr; 459(1):90-111. PubMed ID: 12629668
[TBL] [Abstract][Full Text] [Related]
2. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
3. Absence of cholinergic sympathetic innervation from limb muscle vasculature in rats and mice.
Guidry G; Landis SC
Auton Neurosci; 2000 Aug; 82(3):97-108. PubMed ID: 11023615
[TBL] [Abstract][Full Text] [Related]
4. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.
Weihe E; Tao-Cheng JH; Schäfer MK; Erickson JD; Eiden LE
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3547-52. PubMed ID: 8622973
[TBL] [Abstract][Full Text] [Related]
5. Innervation of intestinal arteries by axons with immunoreactivity for the vesicular acetylcholine transporter (VAChT).
Li ZS; Fox-Threlkeld JE; Furness JB
J Anat; 1998 Jan; 192 ( Pt 1)(Pt 1):107-17. PubMed ID: 9568566
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system.
Schäfer MK; Eiden LE; Weihe E
Neuroscience; 1998 May; 84(2):331-59. PubMed ID: 9539209
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter.
Efange SM
FASEB J; 2000 Dec; 14(15):2401-13. PubMed ID: 11099458
[TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
[TBL] [Abstract][Full Text] [Related]
9. Transient developmental expression of monoamine transporters in the rodent forebrain.
Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
[TBL] [Abstract][Full Text] [Related]
10. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
Schütz B; Schäfer MK; Eiden LE; Weihe E
Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
[TBL] [Abstract][Full Text] [Related]
12. Anatomical and neurochemical features of the extrinsic and intrinsic innervation of the striated muscle in the porcine esophagus: evidence for regional and species differences.
Wu M; Majewski M; Wojtkiewicz J; Vanderwinden JM; Adriaensen D; Timmermans JP
Cell Tissue Res; 2003 Mar; 311(3):289-97. PubMed ID: 12658437
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
Varoqui H; Erickson JD
J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
[TBL] [Abstract][Full Text] [Related]
14. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter.
Verney C; Lebrand C; Gaspar P
Anat Rec; 2002 Jun; 267(2):87-93. PubMed ID: 11997877
[TBL] [Abstract][Full Text] [Related]
15. Target-independent cholinergic differentiation in the rat sympathetic nervous system.
Schäfer MK; Schütz B; Weihe E; Eiden LE
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4149-54. PubMed ID: 9108120
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome patients start early prenatal life with normal cholinergic, monoaminergic and serotoninergic innervation.
Lubec B; Yoo BC; Dierssen M; Balic N; Lubec G
J Neural Transm Suppl; 2001; (61):303-10. PubMed ID: 11771753
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity for high-affinity choline transporter colocalises with VAChT in human enteric nervous system.
Harrington AM; Lee M; Ong SY; Yong E; Farmer P; Peck CJ; Chow CW; Hutson JM; Southwell BR
Cell Tissue Res; 2010 Jul; 341(1):33-48. PubMed ID: 20490865
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. II. The peripheral nervous system.
Schäfer MK; Eiden LE; Weihe E
Neuroscience; 1998 May; 84(2):361-76. PubMed ID: 9539210
[TBL] [Abstract][Full Text] [Related]
19. Efferent and afferent innervation of primate trabecular meshwork and scleral spur.
Selbach JM; Gottanka J; Wittmann M; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2184-91. PubMed ID: 10892861
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic innervation and calretinin-immunoreactive neurones in the hippocampus during postnatal development of the rat brain.
Ludkiewicz B; Wójcik S; Spodnik E; Domaradzka-Pytel B; Moryś J
Folia Morphol (Warsz); 2002; 61(1):7-14. PubMed ID: 11905254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]